Piyush Kansagra

Title: The Innovative Mind of Piyush Kansagra

Introduction

Piyush Kansagra, a talented inventor residing in Sanand, India, has made significant contributions to the field of pharmaceuticals. With a total of four patents to his name, Kansagra is recognized for his innovative approaches to drug formulation, particularly in improving the stability and release mechanisms of important medications.

Latest Patents

Kansagra's notable patents include a "Stable Extended Release Pharmaceutical Composition of Clozapine." This invention discloses stable extended release formulations and pharmaceutical compositions that exhibit enhanced stability under various conditions, along with methods for preparing these formulations. Another of his key patents is the "Extended Release Pharmaceutical Composition of Clozapine," which outlines a composition that incorporates Clozapine along with a seal coating, acidic coating, and an extended release coating. This composition is designed for once-a-day administration as a solid oral pharmaceutical formulation, ensuring that a therapeutically effective amount of Clozapine is released over an extended time period.

Career Highlights

Piyush Kansagra plays a pivotal role at Intas Pharmaceuticals Limited, where he has channeled his expertise into developing novel pharmaceutical solutions. His commitment to innovation and excellence in formulation science has enabled him to stand out in a competitive industry, particularly in the crucial area of psychotropic medications.

Collaborations

Throughout his career, Kansagra has collaborated with skilled professionals such as Rikin Patel and Ashish Sehgal. These collaborations have fostered an environment of creativity and knowledge-sharing, allowing for the production of groundbreaking pharmaceutical compositions and formulations.

Conclusion

In summary, Piyush Kansagra is an accomplished inventor making waves in the pharmaceutical industry with his inventive formulations, particularly for Clozapine. His work at Intas Pharmaceuticals Limited and collaborations with fellow innovators highlight his dedication to advancing pharmaceutical science and improving patient care through innovative solutions.